Sonoma Pharmaceuticals is a specialty pharmaceutical company that develops and markets solutions for the treatment of dermatological conditions and tissue care in both humans and animals. Co.'s products include: Celacyn®, a prescription hypochlorous acid based scar management; Ceramax Skin Barrier Cream helps manage dry itchy skin, minor skin irritations, rashes, and inflammation; Alevicyn, a prescription hypochlorous acid based atopic dermatitis; Mondoxyne, a prescription oral tetracycline antibiotic used for the treatment of certain bacterial infections; Microcyn® or Microdacyn60®, a line of products based on electrically charged oxychlorine small molecules.
|
Free OCLS Email Alerts: Get SEC Filing Alerts Get Dividend Alerts |
Strong Buy (4.00 out of 4) 100th percentile
(ranked higher than approx. 100% of all stocks covered)
Based on Zacks ABR data; powered by Xignite |